Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Angina (Verapamil hydrochloride - Angina)

Records returned : 21 (on 29 May 2025 at 12:52:41). Return to search results for ' Angina '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Modified release capsules
Modified release tablets
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Verapamil hydrochloride

Drug:

Verapamil hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Oral solution

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Amlodipine

Drug:

Amlodipine

Indication :

Angina

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Atenolol

Drug:

Atenolol

Indication :

Angina

Status :

Green

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Bisoprolol fumarate

Drug:

Bisoprolol fumarate

Indication :

Angina

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Carvedilol

Drug:

Carvedilol

Indication :

Angina

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Diltiazem hydrochloride

Drug:

Diltiazem hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Modified release tablets

Restrictions / Comments:

Important

Prescribe by BRAND

Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Diltiazem hydrochloride

Drug:

Diltiazem hydrochloride

Indication :

Angina

Status :

Green

Formulations :

Modified release capsules

Restrictions / Comments:

Important

Prescribe by BRAND

Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Glyceryl trinitrate

Drug:

Glyceryl trinitrate

Indication :

Angina

Status :

Green

Formulations :

Sublingual spray
Sublingual tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. Glyceryl trinitrate

Drug:

Glyceryl trinitrate

Indication :

Angina

Status :

Green

Formulations :

Patches

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

21. Glyceryl trinitrate

Drug:

Glyceryl trinitrate

Indication :

Angina

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Isosorbide dinitrate

Drug:

Isosorbide dinitrate

Indication :

Angina

Status :

Green

Formulations :

Modified release tablets
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Isosorbide mononitrate

Drug:

Isosorbide mononitrate

Indication :

Angina

Status :

Green

Formulations :

Tablets

Restrictions / Comments:

Important

Preferred

Twice daily (assymetric) dosing is recommended

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

18. Isosorbide mononitrate

Drug:

Isosorbide mononitrate

Indication :

Angina

Status :

Green (see narrative)

Formulations :

Modified release capsules
Modified release tablets

Restrictions / Comments:

Important

Restricted to when isosorbide mononitrate standard release is not suitable. Primary Care prescribers should follow local advice on the most cost-effective brands. OptimiseRx will be used to identify current recommendations.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :